In the last trading session, 1.26 million Oncology Institute Inc (NASDAQ:TOI) shares changed hands as the company’s beta touched 0.07. With the company’s per share price at $2.05 changed hands at -$0.14 or -6.39% during last session, the market valuation stood at $188.42M. TOI’s last price was a discount, traded about -70.73% off its 52-week high of $3.50. The share price had its 52-week low at $0.13, which suggests the last value was 93.66% up since then. When we look at Oncology Institute Inc’s average trading volume, we note the 10-day average is 2.23 million shares, with the 3-month average coming to 1.76 million.
Analysts gave the Oncology Institute Inc (TOI) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TOI as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Oncology Institute Inc (NASDAQ:TOI) trade information
Instantly TOI was in red as seen at the end of in last trading. With action -10.48%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 376.74%, with the 5-day performance at -10.48% in the red. However, in the 30-day time frame, Oncology Institute Inc (NASDAQ:TOI) is -36.14% down. Looking at the short shares, we see there were 2.41 million shares sold at short interest cover period of 1.11 days.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 74.38% from its current market value. According to analyst projections, TOI’s forecast low is 6 with 10 as the target high. To hit the forecast high, the stock’s price needs a -387.8% plunge from its current level, while the stock would need to soar -192.68% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -488.57%. The 2025 estimates are for Oncology Institute Inc earnings to increase by 46.48%.
TOI Dividends
Oncology Institute Inc is expected to release its next quarterly earnings report on 2024-Aug-13.
Oncology Institute Inc (NASDAQ:TOI)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.22% of Oncology Institute Inc shares while 34.67% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 38.19%. There are 34.67% institutions holding the Oncology Institute Inc stock share, with FMR LLC the top institutional holder. As of 2024-06-30, the company held 6.4005% of the shares, roughly 4.75 million TOI shares worth $2.19 million.
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds the second largest percentage of outstanding shares, with 4.5263% or 3.36 million shares worth $1.55 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.27 shares estimated at $2.61 million under it, the former controlled 1.39% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.46% of the shares, roughly 422.98 shares worth around $0.87 million.
